Actively Recruiting
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
Led by Sun Yat-sen University · Updated on 2026-04-13
2000
Participants Needed
1
Research Sites
530 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective cohort study is designed to examine the association between blood and urine biomarkers (including genetic variants) and long-term kidney disease progression among 2000 Chinese IgA nephropathy patients with relatively normal kidney function (eGFR≥60 ml/min/1.73 m2).
CONDITIONS
Official Title
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female individuals aged 14 years or older
- Patients with biopsy-proven primary IgA nephropathy
- Renal biopsy must include 10 or more glomeruli
- First renal biopsy performed within 3 years
- Estimated glomerular filtration rate (eGFR) of 60 ml/min/1.73 m2 or higher
- Ability to understand and voluntarily sign the informed consent form
You will not qualify if you...
- Having relatives diagnosed with biopsy-proven primary IgA nephropathy
- Secondary IgA nephropathy caused by diseases such as diabetes, chronic liver disease, or systemic lupus erythematosus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
X
Xue Qing Yu, M.D. & Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here